These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35798648)

  • 21. Re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol. 2017;71:606-17.
    Marconi L; MacLennan S; Lam TBL; Canfield SE; Yuan Y; Omar MI; N'Dow J; Sylvester R
    Eur Urol; 2017 Sep; 72(3):e59-e60. PubMed ID: 28629586
    [No Abstract]   [Full Text] [Related]  

  • 22. Re: Robert J. Motzer, Pratik P. Rane, Todd L. Saretsky, et al. Patient-reported Outcome Measurement and Reporting for Patients with Advanced Renal Cell Carcinoma: A Systematic Literature Review. Eur Urol. Eur Urol. 2023;84:406-17.
    Gutiérrez Rojas AF; Fernández D; Diaz Ritter C
    Eur Urol; 2024 Mar; 85(3):e94. PubMed ID: 37802682
    [No Abstract]   [Full Text] [Related]  

  • 23. Reply to Nikolaos Grivas and Henk G. van der Poel's Letter to the Editor re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.019.
    Farinha R; Rosiello G; Puliatti S; Mottrie A
    Eur Urol Focus; 2022 May; 8(3):888-889. PubMed ID: 34031018
    [No Abstract]   [Full Text] [Related]  

  • 24. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
    Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C
    Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982
    [No Abstract]   [Full Text] [Related]  

  • 25. Re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting Functional Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75:766-72: Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
    Takahashi T
    Eur Urol; 2019 Sep; 76(3):e65-e66. PubMed ID: 31164251
    [No Abstract]   [Full Text] [Related]  

  • 26. Reply to Pranav Sharma, Asad Sawar and Philippe Spiess' letter to the editor re: re: Craig Rogers, Ravi Barod, Scott Schwartz, Mani Menon. Endovascular extraction of caval tumor thrombus to facilitate minimally invasive cytoreductive nephrectomy for metastatic kidney cancer. Eur Urol 2015;68:167-8.
    Rogers CG; Barod R; Schwartz S; Menon M
    Eur Urol; 2015 Oct; 68(4):e81. PubMed ID: 26004799
    [No Abstract]   [Full Text] [Related]  

  • 27. Reply to E. Jason Abel Letter to the Editor re: Lorenzo Marconi, Saeed Dabestani, Thomas B. Lam, et al. Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol 2016;69:660-73.
    Marconi L; Lam TB; Bex A; Ljungberg B; Volpe A
    Eur Urol; 2016 Jun; 69(6):e119-20. PubMed ID: 26776936
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Luis Alberto Dorantes-Carrillo, Mario Basulto-Martínez, Rodrigo Suárez-Ibarrola, et al. Retrograde Intrarenal Surgery Versus Miniaturized Percutaneous Nephrolithotomy for Kidney Stones >1 cm: A Systematic Review and Meta-analysis of Randomized Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.02.008.
    Ma Y; Shao H; Wang Y; Gao S
    Eur Urol Focus; 2022 Sep; 8(5):1448-1449. PubMed ID: 34389268
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Steiner T, Knels R, Schubert J. Prognostic significance of tumor size in patients after tumour nephrectomy for localised renal cell carcinoma. Eur Urol 46;2004:327-30.
    Bogdanovic J
    Eur Urol; 2005 Feb; 47(2):266-7. PubMed ID: 15661427
    [No Abstract]   [Full Text] [Related]  

  • 30. Re: Alessandro Uleri, Jean Nicolas Cornu, Andrea Gobbo, et al. Association of 5α-Reductase Inhibitors with Depression and Suicide: A Mini Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.04.009.
    Nguyen DD; Bhojani N; Trinh QD
    Eur Urol Focus; 2024 Jul; ():. PubMed ID: 38997837
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Hiury S. Andrade, Homayoun Zargar, Peter A. Caputo, et al. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. Eur Urol 2016;69:1149-54.
    Shin TY; Abdel Raheem A; Rha KH
    Eur Urol; 2016 Oct; 70(4):e100-e101. PubMed ID: 26995331
    [No Abstract]   [Full Text] [Related]  

  • 32. Re: Christian Moro, Charlotte Phelps, Vineesha Veer, et al. Cranberry Juice, Cranberry Tablets, or Liquid Therapies for Urinary Tract Infection: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2024.07.002.
    Joshi A; Tzelves L; Tandogdu Z; Juliebø-Jones P; Somani B
    Eur Urol Focus; 2024 Sep; ():. PubMed ID: 39341717
    [No Abstract]   [Full Text] [Related]  

  • 33. Re: Günter Janetschek. Laparoscopic partial nephrectomy for RCC: how can we avoid ischemic damage of the renal parenchyma? Eur Urol 2007;52:1303-5.
    Simone G; Guaglianone S; Gallucci M
    Eur Urol; 2008 Jun; 53(6):1302-3; author reply 1303-4. PubMed ID: 18222605
    [No Abstract]   [Full Text] [Related]  

  • 34. Reply to Mengda Zhang and Long Wang's Letter to the Editor re: Francesco Porpiglia, Enrico Checcucci, Daniele Amparore, et al. Three-dimensional Augmented Reality Robot-assisted Partial Nephrectomy in Case of Complex Tumours (PADUA ≥ 10): A New Intraoperative Tool Overcoming the Ultrasound Guidance. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2019.11.024.
    Amparore D; Checcucci E; Fiori C; Porpiglia F
    Eur Urol; 2020 Jun; 77(6):e163-e164. PubMed ID: 32279902
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
    Kim WH; Yoon HK; Jeong CW
    Eur Urol; 2020 Jan; 77(1):e14-e15. PubMed ID: 31586511
    [No Abstract]   [Full Text] [Related]  

  • 36. Re: Maxine Sun, Lorenzo Marconi, Tim Eisen, et al. Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. Eur Urol 2018;74:611-20: Systematic Review Findings on the Role of Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma.
    Hwang EC; Risk MC; Dahm P
    Eur Urol; 2019 Mar; 75(3):e67-e68. PubMed ID: 30466889
    [No Abstract]   [Full Text] [Related]  

  • 37. Re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007.
    Gandaglia G; Briganti A; Raggi D; Marandino L; Necchi A; Di Maio M; Montorsi F
    Eur Urol Focus; 2024 May; 10(3):497. PubMed ID: 36813620
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019:76:136-7.
    Marconi L; Bensalah K; Bex A;
    Eur Urol; 2019 Jul; 76(1):e12-e13. PubMed ID: 30922689
    [No Abstract]   [Full Text] [Related]  

  • 39. Re: Todd M. Morgan, Dominic Tang, Kelly L. Stratton, et al. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma. Eur Urol 2011;59:923-8. Re: Umberto Capitanio, Francesco Montorsi. Does preoperative nutritional status affect survival in renal cell carcinoma? The debate continues. Eur Urol 2011;59:929-30.
    Brookman-May S; Burger M; Wieland WF; May M
    Eur Urol; 2011 Nov; 60(5):e45-6; author reply e47. PubMed ID: 21820239
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: Keiichiro Mori, Mohammad Abufaraj, Hadi Mostafaei, et al. The Predictive Value of Programmed Death Ligand 1 in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-checkpoint Inhibitors: A Systematic Review and Meta-analysis. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.10.006: Clinical Activity of Immune Checkpoint Inhibitors: Is the Host the Answer?
    Noel J; Huillard O; Goldwasser F
    Eur Urol; 2021 Apr; 79(4):e112. PubMed ID: 33518379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.